chr19-10287757-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001544.5(ICAM4):c.616C>A(p.Gln206Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,576 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001544.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ICAM4 | NM_001544.5 | c.616C>A | p.Gln206Lys | missense_variant | 2/3 | ENST00000380770.5 | |
ICAM4 | NM_001039132.3 | c.539C>A | p.Ala180Glu | missense_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ICAM4 | ENST00000380770.5 | c.616C>A | p.Gln206Lys | missense_variant | 2/3 | 1 | NM_001544.5 | P2 | |
ICAM4 | ENST00000340992.4 | c.539C>A | p.Ala180Glu | missense_variant | 2/3 | 1 | |||
ICAM4-AS1 | ENST00000589379.1 | n.1263G>T | non_coding_transcript_exon_variant | 1/1 | |||||
ICAM4 | ENST00000393717.2 | c.616C>A | p.Gln206Lys | missense_variant | 2/2 | 2 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461576Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727122
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 14, 2023 | The c.616C>A (p.Q206K) alteration is located in exon 2 (coding exon 2) of the ICAM4 gene. This alteration results from a C to A substitution at nucleotide position 616, causing the glutamine (Q) at amino acid position 206 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at